Year |
Citation |
Score |
2020 |
Chi F, Liu J, Brady SW, Cosgrove PA, Nath A, McQuerry JA, Majumdar S, Moos PJ, Chang JT, Kahn M, Bild AH. A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer. Translational Oncology. 14: 100946. PMID 33221681 DOI: 10.1016/j.tranon.2020.100946 |
0.317 |
|
2014 |
Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, Coram MA, Piskun CM, Longacre TA, Herrler M, Frimannsson DO, Telli ML, Dirbas FM, Matin AC, Dairkee SH, ... ... Bild AH, et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Breast Cancer Research : Bcr. 16: R36. PMID 24708766 DOI: 10.1186/Bcr3640 |
0.316 |
|
2006 |
Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA, Marks JR, Dressman HK, West M, Nevins JR. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 439: 353-7. PMID 16273092 DOI: 10.1038/Nature04296 |
0.306 |
|
2006 |
Potti A, Dressman HK, Bild A, Riedel R, Kelley M, Ginsburg G, Lancaster J, Nevins J, Febbo P. A genomic strategy to combinatorial therapeutics in solid tumors Journal of Clinical Oncology. 24: 2031-2031. DOI: 10.1200/Jco.2006.24.18_Suppl.2031 |
0.305 |
|
Show low-probability matches. |